KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Vir Biotechnology (VIR) Return on Equity (2019 - 2025)

Vir Biotechnology's Return on Equity history spans 7 years, with the latest figure at 0.01% for Q4 2025.

  • On a quarterly basis, Return on Equity changed 0.0% to 0.01% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.01%, a 0.0% change, with the full-year FY2025 number at 0.0%, changed 0.0% from a year prior.
  • Return on Equity hit 0.01% in Q4 2025 for Vir Biotechnology, up from 0.01% in the prior quarter.
  • Over the last five years, Return on Equity for VIR hit a ceiling of 0.01% in Q1 2022 and a floor of 0.01% in Q3 2025.
  • Historically, Return on Equity has averaged 0.0% across 5 years, with a median of 0.0% in 2023.
  • Biggest five-year swings in Return on Equity: rose 1bps in 2021 and later decreased -1bps in 2023.
  • Tracing VIR's Return on Equity over 5 years: stood at 0.0% in 2021, then plummeted by -47bps to 0.0% in 2022, then plummeted by -254bps to 0.0% in 2023, then fell by -16bps to 0.0% in 2024, then fell by -29bps to 0.01% in 2025.
  • Business Quant data shows Return on Equity for VIR at 0.01% in Q4 2025, 0.01% in Q3 2025, and 0.01% in Q2 2025.